RecruitingNot ApplicableNCT03527420
DNA Methylation and Vascular Function
DNA Methylation and Vascular Function in Obesity: Role of Exercise and Weight Loss
Sponsor
University of Illinois at Chicago
Enrollment
80 participants
Start Date
Oct 11, 2019
Study Type
INTERVENTIONAL
Conditions
Summary
The main objective is to examine DNA hypomethylation as an underlying mechanism for the increased production of inflammatory cytokines and the impaired vascular function in obese individuals and as a potential target for nonpharmacological preventive/therapeutic interventions such as aerobic exercise.
Eligibility
Min Age: 18 YearsMax Age: 50 Years
Inclusion Criteria4
- BMI ≥ 35 kg/m2
- Between ages 18-50 years
- Not pregnant
- Approved for a bariatric surgery
Exclusion Criteria4
- To avoid confounding from other inflammatory conditions individuals with current cancer, heart, kidney or liver disease, gallbladder disease or acute or chronic inflammatory diseases (including rheumatoid arthritis, lupus and other autoimmune diseases and genetic diseases) will be excluded
- Pregnant women will be excluded, as they will not be eligible for bariatric surgery
- Current smokers
- Currently abusing alcohol or drugs
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERExercise training
Twelve weeks of aerobic exercise training
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03527420
Related Trials
RemI for Post-Bariatric Surgery Weight Regain
NCT062929362 locations
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459586 locations
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
NCT0722568637 locations
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
NCT011434543 locations
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
NCT07253285119 locations